Status:
RECRUITING
Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH)
Lead Sponsor:
Montefiore Medical Center
Collaborating Sponsors:
Geisinger Clinic
Heidelberg University
Conditions:
Chronic Subdural Hematoma
Eligibility:
All Genders
18+ years
Brief Summary
This multi-center retrospective cohort study aims to investigate the real-world outcomes of chronic subdural hematoma treated with MMAE, including clinical effectiveness, recurrence rates, and safety ...
Detailed Description
Chronic subdural hematoma (cSDH) is a prevalent neurosurgical condition marked by the accumulation of blood in the subarachnoid space. Primarily affecting elderly individuals, cSDH is associated with ...
Eligibility Criteria
Inclusion
- Consecutive adult patients (18 yrs. of age or older)
- Endovascular embolization of middle meningeal artery using any embolization material:
- PVA particles; Onyx, nBCA glue; dimethyl sulfoxide, microcoils, PVA with microcoils
Exclusion
- Endovascular embolization of middle meningeal artery using any other embolization material
Key Trial Info
Start Date :
December 5 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2026
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT06181994
Start Date
December 5 2023
End Date
August 1 2026
Last Update
January 7 2026
Active Locations (19)
Enter a location and click search to find clinical trials sorted by distance.
1
Baptist Health South Florida, Inc.
Coral Gables, Florida, United States, 33143
2
Mayo Clinic Florida
Jacksonville, Florida, United States, 32224
3
Orlando Regional Medical Center
Orlando, Florida, United States, 32806
4
University of Illinois Chicago
Chicago, Illinois, United States, 60607